Novanta
✦ Quant Fair Value how this is computed
- Implied fair-value range of 102.13-145.65, from this stock's own trailing 5-year average P/E applied to trailing EPS.
- Current price is -17.7% below the average-multiple fair value of 123.89.
Valuation each multiple against its own 5-year range
Vs. peers Scientific & Technical Instruments
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Novanta (NOVT) | 3.86B | 77.27 | 2.37 | 0.00% |
| Garmin (GRMN) | 51.65B | 25.75 | 5.41 | 1.46% |
| Keysight Technologies (KEYS) | 44.43B | 29.89 | 6.39 | 0.00% |
| Coherent (COHR) | 36.87B | 38.76 | 3.25 | 0.00% |
| Teledyne Technologies (TDY) | 27.56B | 27.41 | 2.47 | 0.00% |
| Fortive (FTV) | 19.10B | 30.85 | 3.21 | 0.39% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 26.3% below Morningstar's fair value estimate.
Fair value
Novanta Inc receives a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 8% discount to our quantitative fair value estimate of $128.82 per share; however, some caution is warranted due to this estimate's medium uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.
We need more explanatory data to elaborate on this stock's star rating. We strive to explain the factors driving every rating we assign; however, this is not yet possible for a small fraction of our coverage universe.
Economic moat
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
By Quantitative Equity Report
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
Novanta discussion 0 comments